4.6 Article

Cancer-of-Unknown-Primary-Origin: A SEER-Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design

Jeffrey S. Ross et al.

Summary: The retrospective analysis of CUP cases confirmed the eligibility of patients for targeted or immunotherapy treatment arms in the ongoing CUPISCO trial. The study suggests that future research may identify a greater proportion of CUP patients who could benefit from comprehensive genomic profiling-informed treatment by including additional biomarkers and treatment arms such as PD-L1 positivity and genomic loss of heterozygosity.

ONCOLOGIST (2021)

Article Oncology

A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience

Chantal Pauli et al.

Summary: The ongoing CUPISCO trial aims to compare molecularly guided therapy with platinum-based chemotherapy in patients newly diagnosed with unfavorable cancer of unknown primary (CUP). By sharing experiences, the study aims to improve understanding of diagnostic challenges and clinical CUP algorithms. The challenges of definitively distinguishing CUP from other cancer types in an international clinical trial setting is highlighted, leading to implications for future studies aiming to find better treatment strategies for CUP.

ONCOLOGIST (2021)

Review Oncology

Cancer of Unknown Primary in the Molecular Era

Shumei Kato et al.

Summary: CUP is a rare malignancy with unknown primary origin, presenting challenges in treatment. Recent research suggests that genomic alterations may be crucial for diagnosis, and personalized combination therapy based on genomic alterations is a promising avenue for future clinical investigation.

TRENDS IN CANCER (2021)

Review Oncology

New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?

Elie Rassy et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)

Review Oncology

Metastatic Cancer of Unknown Primary or Primary Metastatic Cancer?

Stefan Kolling et al.

FRONTIERS IN ONCOLOGY (2020)

Review Oncology

Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity?

Tilmann Bochtler et al.

FRONTIERS IN ONCOLOGY (2019)

Article Oncology

The currently declining incidence of cancer of unknown primary

Elie Rassy et al.

CANCER EPIDEMIOLOGY (2019)

Article Oncology

SEOM clinical guideline on unknown primary cancer (2017)

F. Losa et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2018)

Article Oncology

Cancer of unknown primary ultimately diagnosed as male breast cancer: A rare case report

Georgios Rigakos et al.

MOLECULAR AND CLINICAL ONCOLOGY (2016)

Article Medicine, General & Internal

A Simple Risk Model to Predict Survival in Patients With Carcinoma of Unknown Primary Origin

Chen-Yang Huang et al.

MEDICINE (2015)

Article Oncology

Cancer of unknown primary: time trends in incidence, United States

Elena Mnatsakanyan et al.

CANCER CAUSES & CONTROL (2014)

Article Oncology

Power and limits of modern cancer diagnostics: cancer of unknown primary

K. Hemminki et al.

ANNALS OF ONCOLOGY (2012)

Review Medicine, Research & Experimental

Cancers of unknown primary origin: current perspectives and future therapeutic strategies

Giulia Maria Stella et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2012)